
IndraLab
Statements
Cis-doxepin inhibits KCNH2. 8 / 8
|
8
reach
"TCAs are associated with QT c interval lengthening in clinical use XREF_BIBR, and I HERG inhibition by doxepin observed in the present study is consistent both with documented cases of QT interval prolongation and TdP with doxepin XREF_BIBR and with QT interval increases seen in anaesthetised guinea-pigs receiving doxepin infusion XREF_BIBR."